OUR PORTFOLIO

Our portfolio includes grants and mission-related investments supporting Alzheimer’s drugs in development, biomarkers, prevention programs, and other projects designed to build the capacity of the field. You can explore the programs we have supported using the filter and “Search Database” options in the sidebar.

All Filters

Clear
Clear
Clear
Clear
Clear
Clear
Clear
Investigator: Irina Pikuleva

1 Projects | 1 Researchers | $794,596 Invested

2016

Case Western Reserve University

Irina Pikuleva, PhD

Cholesterol-metabolizing enzyme CYP46A1 as a new therapeutic target for Alzheimer's disease

  • Funding Amount: $794,596
  • Organization Type: Academic/Nonprofit
  • Program: Clinical
  • Target: Other
  • Status: Closed